Abiopharma

Ascendis Pharma (ASND) Files Form 6-K

Community Health Systems Appoints Kevin Hammons Chief Executive Officer and Jason Johnson Chief Financial Officer

Clearmind Medicine Announces 1-for-40 Reverse Share Split

Avricore Health Inc. (AVCRF) Files Form 6-K

New Form 3 - Butterfly Network, Inc. Filed: 2025-12-10 AccNo: 0002064832-25-000081 Size: 7 KB

Kazia Therapeutics Limited (KZIA) Files Form 6-K

New Form S-1 - Azitra, Inc. Filed: 2025-12-10 AccNo: 0001493152-25-027067 Size: 1 MB

New Form S-8 - GALAPAGOS NV Filed: 2025-12-10 AccNo: 0001104659-25-119980 Size: 572 KB

Smith Beth Ann 🟢 acquired 25.0K shares (1 derivative) of MACROGENICS INC (MGNX) at $1.33 Transaction Date: Dec 08, 2025 | Filing ID: 000004

New Form S-3 - Prelude Therapeutics Inc Filed: 2025-12-10 AccNo: 0000929638-25-004572 Size: 268 KB

Director Hoppenot Herve 🔴 sold 2.8K shares of INCYTE CORP (INCY) at $96.70 Transaction Date: Dec 08, 2025 | Filing ID: 000010

(99% Neutral) 4D Molecular Therapeutics, Inc. (FDMT) Announces Clinical Development Update

New Form D - Verrica Pharmaceuticals Inc. Filed: 2025-12-10 AccNo: 0001231919-25-000594 Size: 15 KB

(85% Positive) GRI BIO, INC. (GRI) Provides Update on decline for up to a year

📋 HOWARD HORN (Officer) plans to sell 3K shares of ULTRAGENYX PHARMACEUTICAL INC. (at $36.38 each, total $112K) Filed: Dec 10, 2025 | ID: 010053